Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Colorimetric Bandages Identify and Treat Bacterial Infections

By HospiMedica International staff writers
Posted on 10 Feb 2020
Innovative color-changing bandages can sense drug-resistant and drug-sensitive bacteria in wounds and treat them accordingly, claims a new study.

Developed at the Chinese Academy of Sciences (CAS; Shenyang, China) and the University of Science and Technology of China (USTC; Hefei, China), the new paper-based bandaid (PBB) visually implements a selective antibacterial strategy. The PBB changes color from green to yellow when it contacts the acidic microenvironment of a bacterial infection; if drug-resistant bacteria are present, the bandage turns red in color through the action of an enzyme produced by the resistant microbes.

If an infection is detected, the PBB releases an antibiotic that kills drug-sensitive bacteria. When drug resistant bacteria are detected, Zr-MOF PCN-224-based photodynamic therapy (PDT) is used on the wound site to treat the resistant strains by releasing reactive oxygen species (ROS) that kill or weaken the bacteria, making them more susceptible to the antibiotic. The limit of detection is 104 CFU/mL for drug-resistant E. coli. The study was published on January 29, 2020, in ACS Central Science.

“Compared with traditional PDT-based antibacterial strategies, our design can alleviate off-target side effects, maximize therapeutic efficacy, and track the drug resistance in real time with the naked eye,” concluded senior author Xiaogang Qu, PhD, of the CAS Changchun Institute of Applied Chemistry, and colleagues. “This work develops a new way for the rational use of antibiotics. Given the low cost and easy operation of this point-of-care device, it can be developed for practical applications.”

PDT is used clinically to treat a wide range of medical conditions, including wet age-related macular degeneration and malignant cancers, and is recognized as a treatment strategy which is both minimally invasive and minimally toxic. While the applicability and potential of PDT has been known for over a hundred years, the development of modern PDT has been a gradual one, involving scientific progress in the fields of photobiology and cancer biology, as well as the development of modern photonic devices, such as lasers and light emitting diodes (LEDs).

Related Links:
Chinese Academy of Sciences
University of Science and Technology of China



Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Total Ankle Prosthesis
SALTO TALARIS
New
Ultrasonic Cleaners
Large-Capacity Ultrasonic Cleaners
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The stretchy hydrogel and a vial of liquid polymer (Photo courtesy of WPI)

New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants

Medical devices and human tissues differ significantly in their composition. While medical devices are primarily constructed from hard materials like metal and plastic, human tissue is soft and moist.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.